Dalmark Pharma Chem Private Limited
About Dalmark Pharma Chem Private Limited
Data last updated:
Dalmark Pharma Chem Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2020PTC344094. Its GSTIN is 08AAICD0785A1ZV (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹20,000. It is led by directors Monil Nandawat and Dinesh Kumar Malara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 402 New Ambica Develpoers Plot 20 Sec 25, Navi Mumbai, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.33 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹18,696 (net margin 0.3%) and EBITDA of ₹25,265 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 402 New Ambica Develpoers Plot 20 Sec 25, Navi Mumbai, Maharashtra, India – 410206
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dalmark Pharma Chem Private Limited
The main business activity of Dalmark Pharma Chem is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dalmark Pharma Chem Private Limited FY 2025 filings available
Dalmark Pharma Chem Private Limited reported revenue of ₹54.33 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dalmark Pharma Chem Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 42% over three years, including 8% growth in the latest year. EBITDA fell 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dalmark Pharma Chem Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹25,265 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18,696 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dalmark Pharma Chem Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dalmark Pharma Chem are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parkar Agrotech Private Limited | ₹54.36 Lakh (FY 2023) | •••• | •••• | -92.0% | •••• | Navi Mumbai, Maharashtra, India |
| Aps Beverages & Foods Private Limited | ₹54.35 Lakh (FY 2025) | •••• | •••• | 30.0% | •••• | Varanasi, Uttar Pradesh, India |
| Tressmart Marketing Private Limited | ₹54.35 Lakh (FY 2025) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Nano Magic World Private Limited | ₹54.33 Lakh (FY 2024) | •••• | •••• | 71.0% | •••• | Gurgaon, Haryana, India |
| Jai Bharat Business House Private Limited | ₹54.33 Lakh (FY 2022) | •••• | •••• | 13.0% | •••• | Chandigarh, India |
| Dalmark Pharma Chem Private Limited this company | ₹54.33 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Navi Mumbai, Maharashtra, India |
| Pragya Global Private Limited | ₹54.33 Lakh (FY 2024) | •••• | •••• | -44.0% | •••• | Jaipur, Rajasthan, India |
| Sunray Globaltex Private Limited | ₹54.32 Lakh (FY 2025) | •••• | •••• | -71.0% | •••• | Sirsa, Haryana, India |
| RX Medmart Private Limited | ₹54.32 Lakh (FY 2025) | •••• | •••• | 30.0% | •••• | Delhi, India |
| Bitline Technologies Private Limited | ₹54.32 Lakh (FY 2019) | •••• | •••• | 353.0% | •••• | Udupi, Karnataka, India |
| JRRS Infratrade Private Limited | ₹54.32 Lakh (FY 2024) | •••• | •••• | 25.0% | •••• | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Dalmark Pharma Chem by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem Private Limited is audited by SANDEEP BONGIRWAR & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANDEEP BONGIRWAR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monil Nandawat | Director | 19 Aug 2020 | 6 Years 1 Months | Current |
| Dinesh Kumar Malara | Director | 19 Aug 2020 | 6 Years 1 Months | Current |
Ownership and Shareholding of Dalmark Pharma Chem Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem Private Limited has a workforce of 0 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Dinesh Kumar Malara was appointed as Director on 19 Aug 2020.
Credit Ratings, Litigation & Regulatory Alerts for Dalmark Pharma Chem Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dalmark Pharma Chem Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dalmark Pharma Chem Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAICD0785A1ZV | Rajasthan | Active | 05 Nov 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dalmark Pharma Chem Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dalmark Pharma Chem Private Limited
Dalmark Pharma Chem is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 August 2020 (6+ years old) and is registered under CIN U24233MH2020PTC344094.
Dalmark Pharma Chem reported revenue of ₹54.33 Lakh for FY 2025 (up 8% YoY).
Dalmark Pharma Chem has 2 current directors:
- Monil Nandawat - Director
- Dinesh Kumar Malara - Director
Dalmark Pharma Chem reported a net profit of ₹18,696 (net margin 0.3%) and EBITDA of ₹25,265 (EBITDA margin 0.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dalmark Pharma Chem is 42% over three years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dalmark Pharma Chem is 08AAICD0785A1ZV, registered in Rajasthan.
The CIN (Corporate Identification Number) of Dalmark Pharma Chem is U24233MH2020PTC344094. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dalmark Pharma Chem was incorporated on 19 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dalmark Pharma Chem by revenue are Parkar Agrotech Private Limited, Aps Beverages & Foods Private Limited, Tressmart Marketing Private Limited, Nano Magic World Private Limited, Jai Bharat Business House Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Dinesh Kumar Malara was appointed as Director on 19 Aug 2020. Monil Nandawat was appointed as Director on 19 Aug 2020.
The registered office of Dalmark Pharma Chem is at A – 402 New Ambica Develpoers Plot 20 Sec 25, Navi Mumbai, Maharashtra, India – 410206.